SKYE Skye Bioscience, Inc.
Nasdaq · SEC CIK 1516551 · EDGAR
- Bought, last 12 months
- $0 0 purchases by 0 insiders
- Sold, last 12 months
- $889.2K 6 sales by 2 insiders
- Filings on record
- 105 since 2021-07-26, latest 2026-09-24 16:31
BoughtSold
Most active insiders, 12 months
| Insider | Title | Bought | Sold |
|---|---|---|---|
| 5AM Partners VII, LLC | 10% | — | $444.6K |
| Schwab Andrew J. | Dir, 10% | — | $444.6K |
| DHILLON PUNIT | CEO, Dir | — | — |
Transactions 45
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| MI | 2026-09-24 16:31 | 2026-09-22+ | SKYE | Schwab Andrew J. | Dir, 10% | S - Sale | $1.62 | -148.1K | 0 | -100% | -$239.6K |
| MI | 2026-09-24 16:29 | 2026-09-22+ | SKYE | 5AM Partners VII, LLC | 10% | S - Sale | $1.62 | -148.1K | 0 | -100% | -$239.6K |
| MI | 2026-09-18 18:39 | 2026-09-16 | SKYE | Schwab Andrew J. | Dir, 10% | S - Sale | $1.91 | -33.9K | 5,616 | -86% | -$64.7K |
| MI | 2026-09-18 18:37 | 2026-09-16 | SKYE | 5AM Partners VII, LLC | 10% | S - Sale | $1.91 | -33.9K | 5,616 | -86% | -$64.7K |
| MI | 2026-08-20 17:59 | 2026-08-18+ | SKYE | Schwab Andrew J. | Dir, 10% | S - Sale | $0.3733 | -375.8K | 7.85M | -5% | -$140.3K |
| MI | 2026-08-20 17:57 | 2026-08-18+ | SKYE | 5AM Partners VII, LLC | 10% | S - Sale | $0.3733 | -375.8K | 7.85M | -5% | -$140.3K |
| 2026-08-07 17:37 | 2026-08-07 | SKYE | DHILLON PUNIT | CEO, Dir | A - Grant | $0.00 | +1.09M | 1.42M | +330% | $0 | |
| MI | 2025-08-22 | 2025-08-21+ | SKYE | ROCKLAGE SCOTT M | 10% | S - Sale | $3.46 | -231.4K | 64.0K | -78% | -$800.5K |
| MI | 2025-08-22 | 2025-08-21+ | SKYE | Schwab Andrew J. | Dir, 10% | S - Sale | $3.46 | -231.4K | 64.0K | -78% | -$800.5K |
| MA | 2025-02-28 | 2024-11-15+ | SKYE | ARSENAULT KAITLYN | CFO | S - Sale | $4.99 | -43.2K | 167.5K | -21% | -$215.8K |
| M | 2024-11-20 | 2024-11-15+ | SKYE | Diep Tuan Tu | Chief Development Off | S - Sale | $4.99 | -19.6K | 82.3K | -19% | -$97.7K |
| M | 2024-11-19 | 2024-11-15+ | SKYE | ARSENAULT KAITLYN | CFO | S - Sale | $4.99 | -43.4K | 166.3K | -21% | -$216.7K |
| M | 2024-11-19 | 2024-11-15+ | SKYE | DHILLON PUNIT | CEO, Dir | S - Sale | $4.99 | -82.9K | 412.4K | -17% | -$413.9K |
| M | 2024-11-19 | 2024-11-15+ | SKYE | Grayson Paul A. | Dir | S - Sale | $4.99 | -86.6K | 345.9K | -20% | -$432.1K |
| MI | 2024-09-13 | 2024-09-11+ | SKYE | 5AM Ventures VII, L.P. | 10% | S - Sale | $6.57 | -266.3K | 66.3K | -80% | -$1.75M |
| MI | 2024-09-13 | 2024-09-11+ | SKYE | Schwab Andrew J. | Dir, 10% | S - Sale | $6.57 | -266.3K | 66.4K | -80% | -$1.75M |
| 2024-08-27 | 2024-08-26 | SKYE | DHILLON PUNIT | CEO, Dir | J - Other | — | +15.7K | 412.7K | +4% | — | |
| I | 2024-03-15 | 2024-03-13 | SKYE | Schwab Andrew J. | Dir, 10% | A - Grant | $10.00 | +450.0K | 8.39M | +6% | +$4.50M |
| I | 2024-03-15 | 2024-03-13 | SKYE | PARMAR KUSH | 10% | P - Purchase | $10.00 | +450.0K | 8.39M | +6% | +$4.50M |
| D | 2024-03-04 | 2024-02-29 | SKYE | Diep Tuan Tu | Chief Development Off | A - Grant | $0.00 | +25.0K | 101.8K | +33% | $0 |
| D | 2024-03-04 | 2024-02-29 | SKYE | Grayson Paul A. | Dir | A - Grant | $0.00 | +100.0K | 346.3K | +41% | $0 |
| DA | 2024-03-04 | 2024-02-29 | SKYE | DHILLON PUNIT | CEO, Dir | A - Grant | $0.00 | +100.0K | 397.0K | +34% | $0 |
| DA | 2024-03-04 | 2024-02-29 | SKYE | ARSENAULT KAITLYN | CFO | A - Grant | $0.00 | +25.0K | 209.7K | +14% | $0 |
| D | 2024-03-01 | 2024-02-29 | SKYE | ARSENAULT KAITLYN | CFO | A - Grant | $0.00 | +25.0K | 210.7K | +13% | $0 |
| D | 2024-03-01 | 2024-02-29 | SKYE | DHILLON PUNIT | CEO, Dir | A - Grant | $0.00 | +100.0K | 397.0K | +34% | $0 |
| I | 2024-02-02 | 2024-01-31 | SKYE | Schwab Andrew J. | Dir, 10% | A - Grant | $2.31 | +5.21M | 7.94M | +190% | +$12.03M |
| I | 2024-02-02 | 2024-01-31 | SKYE | DIEKMAN JOHN D | 10% | P - Purchase | $2.31 | +5.21M | 7.94M | +190% | +$12.03M |
| D | 2023-11-06 | 2023-11-06 | SKYE | ARSENAULT KAITLYN | CFO | A - Grant | $0.00 | +128.2K | 185.7K | +223% | $0 |
| 2023-11-06 | 2023-11-06 | SKYE | Grayson Paul A. | Dir | A - Grant | $0.00 | +173.7K | 246.3K | +240% | $0 | |
| D | 2023-11-06 | 2023-11-06 | SKYE | DHILLON PUNIT | CEO, Dir | A - Grant | $0.00 | +194.3K | 297.0K | +189% | $0 |
| DMA | 2023-08-31 | 2023-08-23+ | SKYE | DHILLON PUNIT | CEO, Dir | L - Small Acq | $0.0192 | +119.0K | 24.69M | +0.5% | +$2,290 |
| DA | 2023-08-31 | 2023-08-29 | SKYE | DHILLON PUNIT | CEO, Dir | P - Purchase | $0.02 | +881.0K | 25.68M | +4% | +$17.6K |
| DA | 2023-08-31 | 2023-08-25 | SKYE | DHILLON PUNIT | CEO, Dir | A - Grant | — | +20.28M | 24.68M | +460% | — |
| 2023-08-29 | 2023-08-25 | SKYE | Grayson Paul A. | Dir | A - Grant | — | +18.13M | 18.13M | New | — | |
| D | 2023-08-29 | 2023-08-25 | SKYE | ARSENAULT KAITLYN | CFO | A - Grant | $0.00 | +13.38M | 14.38M | +1,338% | $0 |
| D | 2023-08-29 | 2023-08-29 | SKYE | DHILLON PUNIT | CEO, Dir | P - Purchase | $0.02 | +881.0K | 41.55M | +2% | +$17.6K |
| D | 2023-08-29 | 2023-08-25 | SKYE | DHILLON PUNIT | CEO, Dir | A - Grant | — | +20.28M | 40.55M | +100% | — |
| DM | 2023-08-29 | 2023-08-23+ | SKYE | DHILLON PUNIT | CEO, Dir | L - Small Acq | $0.0192 | +119.0K | 40.67M | +0.3% | +$2,290 |
| DMI | 2023-08-22 | 2023-08-18 | SKYE | Schwab Andrew J. | Dir, 10% | A - Grant | $0.01 | +1.13B | 267.60M | New | +$11.31M |
| DM | 2023-03-17 | 2023-02-22 | SKYE | Emerald Health Sciences Inc. | 10% | A - Grant | $0.0343 | +58.02M | 169.41M | +52% | +$1.99M |
| DMI | 2022-11-15 | 2022-11-10 | SKYE | Rai Sukhwinder Singh | Dir | A - Grant | — | +95.7K | 73.6K | New | — |
| DI | 2022-11-15 | 2022-11-10 | SKYE | DHILLON PUNIT | CEO, Dir | A - Grant | — | +2.34M | 2.34M | New | — |
| D | 2022-11-15 | 2022-11-10 | SKYE | DHILLON PUNIT | CEO, Dir | A - Grant | — | +1.41M | 4.41M | +47% | — |
| D | 2021-12-16 | 2021-12-14 | SKYE | DHILLON PUNIT | CEO, Dir | A - Grant | $0.00 | +2.00M | 3.00M | +200% | $0 |
| D | 2021-12-16 | 2021-12-14 | SKYE | Arsenault Kaitlyn Melanie | CFO | A - Grant | — | +1.00M | 1.00M | New | — |
Purchase Sale Sale after option exercise All abbreviations